Skip to content

Remote Ischemic Preconditioning on Brain Injury in Carotid Endarterectomy

Effect of Remote Ischemic Preconditioning on Brain Injury in Carotid Endarterectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03027011
Enrollment
40
Registered
2017-01-20
Start date
2017-03-01
Completion date
2017-12-31
Last updated
2017-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Remote Ischemic Preconditioning

Brief summary

This is a randomized controlled trial designed to test an intervention (Remote ischemic preconditioning) in patients undergoing carotid endarterectomy (CEA).Remote ischemic preconditioning(RIPC) with transient upper limb ischemia/reperfusion is a novel, simple, cost-free,non-pharmacological and non-invasive strategy.The purpose of this study is to evaluate the effects of Remote Ischaemic Preconditioning on perioperative ischaemic injury in patients undergoing carotid endarterectomy compared to control intervention.The outcomes of interest include neurocognitive function,clinical outcomes,and biomarkers of brain injury.

Detailed description

Remote ischemic preconditioning (RIPC) protocol will be induced during anesthesia by 3 cycles of 5-min upper limb ischemia and 5-min reperfusion using a blood pressure cuff inflated to a pressure 200mmHg

Interventions

PROCEDURERemote Ischemic Preconditioning

RIPC will be induced during anesthesia by 3 cycles of 5-min upper limb ischemia and 5-min reperfusion using a blood-pressure cuff inflated to a pressure 200mmHg

PROCEDUREControl

Control group without remote ischemic preconditioning

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing carotid endarterectomy * Patients aged 55 years to 80 years

Exclusion criteria

* Inability to give informed consent * Known Deep venous thrombosis (DVT) in arm * Pre-existing lymphedema or axillary node dissection both arms * Arteriovenous fistula or graft in both arms * Left ventricular ejection fraction less than 50% * Diagnosis of dementia, intellectual disability, or mental illness including depression, anxiety, or schizophrenia

Design outcomes

Primary

MeasureTime frameDescription
S100-beta biomarker48 hours post surgerytested by ELISA

Secondary

MeasureTime frameDescription
Short - term cognitive function1 day before surgery and 1 week post surgeryShort - term cognitive function will be tested by mini-mental state examination
Neuron specific enolase (NSE) biomarker48 hours post surgerytested by ELISA
Sleep quality1 week post surgerySleep quality will be test by medical outcomes study sleep scale

Countries

China

Contacts

Primary ContactChen Xiuxia, MD
cxxlxy@sina.com+86-18052268332

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026